FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

773881003: Antiparkinson therapeutic role (role)

Status: current, Primitive. Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3726863016 Antiparkinson therapeutic role en Synonym Active Case insensitive SNOMED CT core
3726864010 Antiparkinson therapeutic role (role) en Fully specified name Active Case insensitive SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antiparkinson therapeutic role Is a Therapeutic role true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet Plays role True Antiparkinson therapeutic role Inferred relationship Some
Selegiline only product in oromucosal dose form Plays role True Antiparkinson therapeutic role Inferred relationship Some
Carbidopa- and levodopa-containing product in oromucosal dose form Plays role True Antiparkinson therapeutic role Inferred relationship Some
Carbidopa and levodopa only product in oromucosal dose form Plays role True Antiparkinson therapeutic role Inferred relationship Some
Istradefylline-containing product Plays role True Antiparkinson therapeutic role Inferred relationship Some
Istradefylline only product Plays role True Antiparkinson therapeutic role Inferred relationship Some
Istradefylline-containing product in oral dose form Plays role True Antiparkinson therapeutic role Inferred relationship Some
Istradefylline only product in oral dose form Plays role True Antiparkinson therapeutic role Inferred relationship Some
Opicapone 50 mg oral capsule Plays role True Antiparkinson therapeutic role Inferred relationship Some
Opicapone 25 mg oral capsule Plays role True Antiparkinson therapeutic role Inferred relationship Some
Carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet Plays role True Antiparkinson therapeutic role Inferred relationship Some
Carbidopa 50 mg and levodopa 200 mg prolonged-release oral tablet Plays role True Antiparkinson therapeutic role Inferred relationship Some
Bromocriptine (as bromocriptine mesilate) 800 microgram oral tablet Plays role True Antiparkinson therapeutic role Inferred relationship Some
Carbidopa anhydrous (as carbidopa) 25 mg oral tablet Plays role True Antiparkinson therapeutic role Inferred relationship Some
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg oral tablet Plays role True Antiparkinson therapeutic role Inferred relationship Some
Carbidopa anhydrous (as carbidopa) 10 mg and levodopa 100 mg oral tablet Plays role True Antiparkinson therapeutic role Inferred relationship Some
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg oral tablet Plays role True Antiparkinson therapeutic role Inferred relationship Some
Carbidopa anhydrous (as carbidopa) 12.5 mg and levodopa 50 mg oral tablet Plays role True Antiparkinson therapeutic role Inferred relationship Some
Rasagiline (as rasagiline tartrate) 1 mg oral tablet Plays role True Antiparkinson therapeutic role Inferred relationship Some
Rasagiline (as rasagiline mesilate) 1 mg oral tablet Plays role True Antiparkinson therapeutic role Inferred relationship Some
Rasagiline (as rasagiline mesilate) 500 microgram oral tablet Plays role True Antiparkinson therapeutic role Inferred relationship Some
Biperiden hydrochloride 4 mg prolonged-release oral tablet Plays role True Antiparkinson therapeutic role Inferred relationship Some
Pramipexole (as pramipexole dihydrochloride) 3.15 mg prolonged-release oral tablet Plays role True Antiparkinson therapeutic role Inferred relationship Some
Pramipexole (as pramipexole dihydrochloride) 1.05 mg prolonged-release oral tablet Plays role True Antiparkinson therapeutic role Inferred relationship Some
Pramipexole (as pramipexole dihydrochloride) 2.1 mg prolonged-release oral tablet Plays role True Antiparkinson therapeutic role Inferred relationship Some
Pramipexole (as pramipexole dihydrochloride) 520 microgram prolonged-release oral tablet Plays role True Antiparkinson therapeutic role Inferred relationship Some
Pramipexole (as pramipexole dihydrochloride) 260 microgram prolonged-release oral tablet Plays role True Antiparkinson therapeutic role Inferred relationship Some
Piribedil-containing product in oral dose form Plays role True Antiparkinson therapeutic role Inferred relationship Some
Piribedil 50 mg prolonged-release oral tablet Plays role True Antiparkinson therapeutic role Inferred relationship Some
Piribedil-containing product Plays role True Antiparkinson therapeutic role Inferred relationship Some
Piribedil only product Plays role True Antiparkinson therapeutic role Inferred relationship Some
Piribedil only product in oral dose form Plays role True Antiparkinson therapeutic role Inferred relationship Some
Pramipexole (as pramipexole dihydrochloride) 88 microgram oral tablet Plays role True Antiparkinson therapeutic role Inferred relationship Some
Pramipexole (as pramipexole dihydrochloride) 180 microgram oral tablet Plays role True Antiparkinson therapeutic role Inferred relationship Some
Pramipexole (as pramipexole dihydrochloride) 350 microgram oral tablet Plays role True Antiparkinson therapeutic role Inferred relationship Some
Pramipexole (as pramipexole dihydrochloride) 700 microgram oral tablet Plays role True Antiparkinson therapeutic role Inferred relationship Some
Pramipexole (as pramipexole dihydrochloride) 520 microgram oral tablet Plays role True Antiparkinson therapeutic role Inferred relationship Some
Pramipexole (as pramipexole dihydrochloride) 1.57 mg prolonged-release oral tablet Plays role True Antiparkinson therapeutic role Inferred relationship Some
Pramipexole (as pramipexole dihydrochloride) 2.62 mg prolonged-release oral tablet Plays role True Antiparkinson therapeutic role Inferred relationship Some
Pramipexole (as pramipexole dihydrochloride) 1.05 mg oral tablet Plays role True Antiparkinson therapeutic role Inferred relationship Some
Biperiden lactate 5 mg/mL solution for injection Plays role True Antiparkinson therapeutic role Inferred relationship Some
Ropinirole (as ropinirole hydrochloride) 4 mg oral tablet Plays role True Antiparkinson therapeutic role Inferred relationship Some
Ropinirole (as ropinirole hydrochloride) 3 mg oral tablet Plays role True Antiparkinson therapeutic role Inferred relationship Some
Ropinirole (as ropinirole hydrochloride) 500 microgram oral tablet Plays role True Antiparkinson therapeutic role Inferred relationship Some
Rotigotine 125 microgram/hour prolonged-release transdermal patch Plays role True Antiparkinson therapeutic role Inferred relationship Some
Rotigotine 41.667 microgram/hour prolonged-release transdermal patch Plays role True Antiparkinson therapeutic role Inferred relationship Some

Start Previous Page 3 of 3

Reference Sets

Qualifier value foundation reference set

Back to Start